Tuesday, February 06, 2007

 

Position Updates: NTRI, TLAB

via Briefing:

Nutrisystem up 2% yesterday, likely on potential Whitney offer for HLF - Boenning & Scattergood (44.24)

Boenning & Scattergood notes that NTRI was up 2% yesterday, possibly aided by the buyout offer from Whitney & Co for Herbalife (HLF), which values HLF at 9x forward EBITDA; yet the stock quickly rose to a premium as most observers agreed that HLF should fetch over 10x EBITDA. This was also the valuation realized by privately-held Jenny Craig when it sold to Nestle in mid-2006. Firm says that applying a 10x EBITDA multiple to their 2007 est for NTRI and adjusting for cash generates a price range in the mid-$50's, which is below their tgt of $75. However, firm says the issue is growth: both HLF and Jenny Craig were priced as 10%+ sustainable growers, while NTRI recently provided conservative 1Q07 guidance for 40%+ growth. If you look ahead to a slower growth 2008 EBITDA scenario and apply a 10-11x valuation, firm derives a target in the $70's.

Via FlyontheWall:
Follow-up: TLAB upgraded to Buy from Neutral, tgt $12.50@MLCOMerrill upgraded shares of TLAB citing expectations for an improvement in cross-connect demand and margins. The firm expects TLAB to benefit from AT&T new broadband initiatives, a demand recovery at Cingular, T-Mobile 3G deployment plans, and an increase in Sprint/Nextel base stations.

Comments:
dont forget this one from briefing...

06-Feb-07 07:22 ET In Play Adobe Systems initiated with an Outperform at Credit Suisse- tgt $47 (38.44 ) : Credit Suisse initiates ADBE with an Outperform and a $47 tgt saying they believe Adobe is one of the best-positioned large-cap software companies, given its dominant positioning in the digital media business, along with a number of smaller, but rapidly growing plays in the enterprise, mobile, and Web 2.0 markets.
 
Good call- re GE and TKO
 
Post a Comment



<< Home

This page is powered by Blogger. Isn't yours?

 Subscribe in a reader

DISCLAIMER: This is a personal web site, reflecting the opinions of its author. It is not a production of my employer, and it is unaffiliated with any FINRA broker/dealer. Statements on this site do not represent the views or policies of anyone other than myself. The information on this site is provided for discussion purposes only, and are not investing recommendations. Under no circumstances does this information represent a recommendation to buy or sell securities.